• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟酰胺 - N - 甲基转移酶基因rs694539变异与非酒精性脂肪性肝炎患者的关联

Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis.

作者信息

Sazci Ali, Ozel Mavi Deniz, Ergul Emel, Aygun Cem

机构信息

1 Department of Medical Biology and Genetics, Faculty of Medicine, University of Kocaeli , Kocaeli, Turkey .

出版信息

Genet Test Mol Biomarkers. 2013 Nov;17(11):849-53. doi: 10.1089/gtmb.2013.0309. Epub 2013 Aug 21.

DOI:10.1089/gtmb.2013.0309
PMID:23964925
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal hepatic steatosis in the absence of a history of alcohol use and with a prevalence of 15%-45% in developed nations. Nonalcoholic steatohepatitis (NASH) is an advanced stage of NAFLD with a pronounced major inflammatory component. The aim of this study was to investigate the possible role of nicotinamide-N-methyltransferase (NNMT) gene rs694539 variant in the development of NASH. Therefore, we analyzed 80 NASH patients and 183 healthy controls using a polymerase chain reaction-restriction fragment length polymorphism method developed in our laboratory. The NNMT rs694539 variant was found to be significantly associated with NASH (χ(2)=9.349, p=0.009). The individuals with the GG genotype had protection against NASH (χ(2)=3.793, p=0.051, odds ratio [OR]=0.580, 95% confidence interval [CI]=0.334-1.006), whereas the individuals with the AA genotype showed statistically significant increased risk for NASH (χ(2)=7.748, p=0.005, OR=7.338, 95% CI=1.448-37.190). Moreover, the G allele was protective against NASH (χ(2)=7.748, p=0.005, OR=0.136, and 95% CI=0.027-0.691). On the other hand, the A allele was a risk factor for NASH (χ(2)=3.793, p=0.051, OR=1.725, and 95% CI=0.994-2.996). Consequently, the rs694539 variant of NNMT gene is a genetic risk factor for developing NASH.

摘要

非酒精性脂肪性肝病(NAFLD)是无饮酒史情况下肝脏脂肪变性异常最常见的病因,在发达国家患病率为15% - 45%。非酒精性脂肪性肝炎(NASH)是NAFLD的晚期阶段,具有明显的主要炎症成分。本研究的目的是调查烟酰胺 - N - 甲基转移酶(NNMT)基因rs694539变异体在NASH发生发展中的可能作用。因此,我们使用在我们实验室开发的聚合酶链反应 - 限制性片段长度多态性方法分析了80例NASH患者和183例健康对照。发现NNMT rs694539变异体与NASH显著相关(χ(2)=9.349,p = 0.009)。携带GG基因型的个体对NASH有保护作用(χ(2)=3.793,p = 0.051,比值比[OR]=0.580,95%置信区间[CI]=0.334 - 1.006),而携带AA基因型的个体患NASH的风险在统计学上显著增加(χ(2)=7.748,p = 0.005,OR = 7.338,95% CI = 1.448 - 37.190)。此外,G等位基因对NASH有保护作用(χ(2)=7.748,p = 0.005,OR = 0.136,95% CI = 0.027 - 0.691)。另一方面,A等位基因是NASH的危险因素(χ(2)=3.793,p = 0.051,OR = 1.725,95% CI = 0.994 - 2.996)。因此,NNMT基因的rs694539变异体是发生NASH的遗传危险因素。

相似文献

1
Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis.烟酰胺 - N - 甲基转移酶基因rs694539变异与非酒精性脂肪性肝炎患者的关联
Genet Test Mol Biomarkers. 2013 Nov;17(11):849-53. doi: 10.1089/gtmb.2013.0309. Epub 2013 Aug 21.
2
Genetic Variants in nicotinamide-N-methyltransferase (NNMT) gene are related to the stage of non-alcoholic fatty liver disease diagnosed by controlled attenuation parameter (CAP)-fibroscan.烟酰胺 - N - 甲基转移酶(NNMT)基因中的遗传变异与通过受控衰减参数(CAP)- 瞬时弹性成像诊断的非酒精性脂肪性肝病分期相关。
J Gastrointestin Liver Dis. 2018 Sep;27(3):265-272. doi: 10.15403/jgld.2014.1121.273.wsh.
3
Association of Nicotinamide-N-Methyltransferase Gene rs694539 Variant with Epilepsy.烟酰胺-N-甲基转移酶基因 rs694539 变异与癫痫的关联。
Mol Neurobiol. 2016 Aug;53(6):4197-4200. doi: 10.1007/s12035-015-9364-2. Epub 2015 Jul 28.
4
Association of nicotinamide-N-methyltransferase (NNMT) gene rs694539 variant with bipolar disorder.尼古丁酰胺-N-甲基转移酶(NNMT)基因 rs694539 变异与双相情感障碍的关联。
Gene. 2013 Dec 15;532(2):272-5. doi: 10.1016/j.gene.2013.08.077. Epub 2013 Sep 1.
5
Nicotinamide-N-Methyltransferase gene rs694539 variant and migraine risk.烟酰胺 - N - 甲基转移酶基因rs694539变异与偏头痛风险
J Headache Pain. 2016 Dec;17(1):93. doi: 10.1186/s10194-016-0688-8. Epub 2016 Oct 10.
6
Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.过氧化物酶体增殖物激活受体α和γ2 多态性与非酒精性脂肪性肝病:巴西患者的研究。
Gene. 2013 Oct 25;529(2):326-31. doi: 10.1016/j.gene.2013.06.091. Epub 2013 Jul 24.
7
Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)患者的亚甲基四氢叶酸还原酶基因多态性
Cell Biochem Funct. 2008 Apr;26(3):291-6. doi: 10.1002/cbf.1424.
8
Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.中国人 2 型糖尿病患者抵抗素+299A/A 基因型与非酒精性脂肪性肝病的关系。
Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.
9
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.PNPLA3基因分型增加了非酒精性脂肪性肝病肥胖患者患非酒精性脂肪性肝炎的易感性。
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):888-94. doi: 10.1016/j.soard.2014.07.016. Epub 2014 Aug 1.
10
[Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].PNPLA3基因中的rs738409多态性与非酒精性脂肪性肝病的遗传易感性相关
Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):619-23. doi: 10.3760/cma.j.issn.1007-3418.2013.08.013.

引用本文的文献

1
Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.新型三环小分子烟酰胺 N-甲基转移酶抑制剂用于治疗代谢紊乱。
Sci Rep. 2022 Sep 14;12(1):15440. doi: 10.1038/s41598-022-19634-2.
2
Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes.烟酰胺 N-甲基转移酶在肥胖和 2 型糖尿病中的作用。
Biomed Res Int. 2021 Jul 27;2021:9924314. doi: 10.1155/2021/9924314. eCollection 2021.
3
Novel Inhibitors of Nicotinamide--Methyltransferase for the Treatment of Metabolic Disorders.
新型烟酰胺—N—甲基转移酶抑制剂治疗代谢紊乱。
Molecules. 2021 Feb 13;26(4):991. doi: 10.3390/molecules26040991.
4
Nicotinamide -Methyltransferase: Genomic Connection to Disease.烟酰胺甲基转移酶:与疾病的基因组关联
Int J Tryptophan Res. 2020 Jun 4;13:1178646920919770. doi: 10.1177/1178646920919770. eCollection 2020.
5
Nicotinamide and NAFLD: Is There Nothing New Under the Sun?烟酰胺与非酒精性脂肪性肝病:难道太阳底下无新事?
Metabolites. 2019 Sep 10;9(9):180. doi: 10.3390/metabo9090180.
6
NNMT activation can contribute to the development of fatty liver disease by modulating the NAD metabolism.NNMT 的激活可以通过调节 NAD 代谢来促进脂肪肝疾病的发展。
Sci Rep. 2018 Jun 5;8(1):8637. doi: 10.1038/s41598-018-26882-8.
7
Nicotinamide N-methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes.烟酰胺N-甲基转移酶表达在铁过载时降低,加剧小鼠肝细胞毒性。
Hepatol Commun. 2017 Sep 11;1(8):803-815. doi: 10.1002/hep4.1083. eCollection 2017 Oct.
8
Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Obesity in Chinese Han Male College Students.中国汉族男大学生烟酰胺 N-甲基转移酶基因多态性与肥胖的关联。
Biomed Res Int. 2017;2017:2984826. doi: 10.1155/2017/2984826. Epub 2017 Sep 18.
9
Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.烟酰胺N-甲基转移酶:不仅仅是一种维生素B3清除酶。
Trends Endocrinol Metab. 2017 May;28(5):340-353. doi: 10.1016/j.tem.2017.02.004. Epub 2017 Mar 11.
10
Physiological Study on Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Hyperlipidemia.烟酰胺N-甲基转移酶基因多态性与高脂血症关联的生理学研究
Biomed Res Int. 2016;2016:7521942. doi: 10.1155/2016/7521942. Epub 2016 Nov 23.